CLOV vs IMDX
Clover Health Investments Corp (CLOV) versus Insight Molecular Diagnostics Inc. (IMDX) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported IMDX revenue for 2024-12-31 was $1.9M. Net income was -$60.7M. Revenue was up 25.1% from 2023-12-31 to 2024-12-31. IMDX currently screens at market cap $0.
CLOV currently screens at market cap $1.55B. IMDX currently screens at market cap $0.
Not investment advice. Open the CLOV and IMDX stock pages for the full models.
Not investment advice.